Literature DB >> 11762573

Past exposure to vaccines and subsequent risk of Alzheimer's disease.

R Verreault1, D Laurin, J Lindsay, G De Serres.   

Abstract

BACKGROUND: It has been suggested that changes to the immune system could be a factor in age-related conditions such as Alzheimer's disease. Our objective was to examine the association between past exposure to conventional vaccines and risk of Alzheimer's disease.
METHODS: We analyzed data from a representative community sample of subjects 65 years of age or older participating in the Canadian Study of Health and Aging, a prospective cohort study of dementia. Screening and clinical evaluations were done at both baseline and follow-up. Past exposure to vaccines was assessed at baseline by means of a self-administered questionnaire.
RESULTS: Of the 4392 eligible subjects who were cognitively unimpaired and for whom vaccine information was available at baseline (in 1991-1992) and who completed follow-up 5 years later (in 1996-1997), 527 were diagnosed as having cognitive impairment or dementia other than Alzheimer's disease and were excluded from these analyses. Of the remaining subjects, 3682 were cognitively unimpaired at follow-up and 183 were newly diagnosed as having Alzheimer's disease. After adjustment for age, sex and education, past exposure to vaccines against diphtheria or tetanus, poliomyelitis and influenza was associated with lower risk for Alzheimer's disease (odds ratio [OR] 0.41, 95% confidence interval [CI] 0.27-0.62; OR 0.60, 95% CI 0.37-0.99; and OR 0.75, 95% CI 0.54-1.04 respectively) than no exposure to these vaccines.
INTERPRETATION: Past exposure to vaccines against diphtheria or tetanus, poliomyelitis and influenza may protect against subsequent development of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11762573      PMCID: PMC81665     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  10 in total

Review 1.  Alzheimer's disease: a review concerning immune response and microischemia.

Authors:  R L Chorsky; F Yaghmai; W D Hill; E G Stopa
Journal:  Med Hypotheses       Date:  2001-01       Impact factor: 1.538

2.  Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease.

Authors:  M S Cheon; M Bajo; T Gulesserian; N Cairns; G Lubec
Journal:  Electrophoresis       Date:  2001-02       Impact factor: 3.535

3.  The Modified Mini-Mental State (3MS) examination.

Authors:  E L Teng; H C Chui
Journal:  J Clin Psychiatry       Date:  1987-08       Impact factor: 4.384

4.  Alterations in immune functions during normal aging and Alzheimer's disease.

Authors:  C Song; M Vandewoude; W Stevens; L De Clerck; M Van der Planken; A Whelan; H Anisman; A Dossche; M Maes
Journal:  Psychiatry Res       Date:  1999-01-18       Impact factor: 3.222

5.  The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group.

Authors: 
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

Review 6.  Ageing and the immune system.

Authors:  R B Effros
Journal:  Novartis Found Symp       Date:  2001

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  A sero-epidemiological study of conventional infectious agents in Alzheimer's disease.

Authors:  E B Renvoize; I O Awad; M H Hambling
Journal:  Age Ageing       Date:  1987-09       Impact factor: 10.668

9.  Hypothesis: is Alzheimer's disease a metal-induced immune disorder?

Authors:  R A Armstrong; S J Winsper; J A Blair
Journal:  Neurodegeneration       Date:  1995-03

10.  Canadian study of health and aging: study methods and prevalence of dementia.

Authors: 
Journal:  CMAJ       Date:  1994-03-15       Impact factor: 8.262

  10 in total
  35 in total

1.  Alzheimer's disease and herpes.

Authors:  Ruth F Itzhaki; Curtis B Dobson
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

Review 2.  Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics.

Authors:  Kelly M Bakulski; Laura S Rozek; Dana C Dolinoy; Henry L Paulson; Howard Hu
Journal:  Curr Alzheimer Res       Date:  2012-06       Impact factor: 3.498

Review 3.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 4.  Systemic inflammation and delirium: important co-factors in the progression of dementia.

Authors:  Colm Cunningham
Journal:  Biochem Soc Trans       Date:  2011-08       Impact factor: 5.407

5.  The Role of Chronic Infection in Alzheimer's Disease: Instigators, Co-conspirators, or Bystanders?

Authors:  Lauren Butler; Keenan A Walker
Journal:  Curr Clin Microbiol Rep       Date:  2021-04-24

6.  Adult Vaccination as a Protective Factor for Dementia: A Meta-Analysis and Systematic Review of Population-Based Observational Studies.

Authors:  Xinhui Wu; Haixia Yang; Sixian He; Ting Xia; Diang Chen; Yexin Zhou; Jin Liu; MengSi Liu; Zhen Sun
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

Review 7.  Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  Clive Holmes; Darren Cotterell
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

8.  Herpes Zoster Vaccination Reduces Risk of Dementia.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

Review 9.  Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer's Disease (AD); Underwhelming Evidence against.

Authors:  Ruth F Itzhaki
Journal:  Vaccines (Basel)       Date:  2021-06-21

10.  Potential Virus Involvement in Alzheimer's Disease: Results from a Phase IIa Trial Evaluating Apovir, an Antiviral Drug Combination.

Authors:  Nina Lindblom; Lars Lindquist; Jacob Westman; Mikael Åström; Roger Bullock; Suzanne Hendrix; Lars-Olof Wahlund
Journal:  J Alzheimers Dis Rep       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.